CN1965823B - (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione, its preparation method and its compound - Google Patents

(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione, its preparation method and its compound Download PDF

Info

Publication number
CN1965823B
CN1965823B CN2006101374074A CN200610137407A CN1965823B CN 1965823 B CN1965823 B CN 1965823B CN 2006101374074 A CN2006101374074 A CN 2006101374074A CN 200610137407 A CN200610137407 A CN 200610137407A CN 1965823 B CN1965823 B CN 1965823B
Authority
CN
China
Prior art keywords
purposes
medicine
treatment
day
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2006101374074A
Other languages
Chinese (zh)
Other versions
CN1965823A (en
Inventor
P·H·谢菲尔
G·W·穆勒
H·-W·满
C·葛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Europe GmbH
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US36651502P priority Critical
Priority to US60/366515 priority
Priority to US43845003P priority
Priority to US60/438450 priority
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of CN1965823A publication Critical patent/CN1965823A/en
Application granted granted Critical
Publication of CN1965823B publication Critical patent/CN1965823B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links